MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW)

CUSIP: 58507N113

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 12/22/202
Total 13F shares
4,556,325
Share change
+333,579
Total reported value
$2,391,000
Price per share
$0.52
Number of holders
27
Value change
+$109,581
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 58507N113?
CUSIP 58507N113 identifies MTACW - MEDTECH ACQUISITION CORP - *W EXP 12/22/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) as of Q4 2021

As of 31 Dec 2021, MEDTECH ACQUISITION CORP - *W EXP 12/22/202 (MTACW) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,556,325 shares. The largest 10 holders included BlackRock Inc., Magnetar Financial LLC, Park West Asset Management LLC, ARISTEIA CAPITAL LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Governors Lane LP, Linden Advisors LP, SPRING CREEK CAPITAL LLC, Vestcor Inc, and Kepos Capital LP. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.